Holdings of ENAVATE SCIENCES GP, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 7 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Sionna Therapeutics Inc | 2,478,030 | 99.3M $ | |
| 2 | Immunome Inc | 3,613,799 | 79M $ | |
| 3 | ZENAS BIOPHARMA INC | 3,919,159 | 76.6M $ | |
| 4 | Compass Therapeutics Inc | 7,788,150 | 41.2M $ | |
| 5 | BridgeBio Oncology Therapeutics Inc | 2,626,946 | 23.5M $ | |
| 6 | Upstream Bio Inc | 2,459,703 | 22.1M $ | |
| 7 | CAMP4 Therapeutics Corp | 2,190,920 | 9.7M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 7 | 351.5M $ | 100.00 % |
Cite this page
Titelia. "Holdings of ENAVATE SCIENCES GP, LLC". https://titelia.com/en/funds/US13F1953107